Mark Mellett

970 citations
30 papers · 674 indexed · h-index 13

Mark Mellett

28 papers receiving 669 citations

Peers

Mark Mellett
Comparison fields: 5 of 81
  • Dermatology 167
  • Immunology 360
  • Cancer Research 80
  • Rheumatology 60
  • Pathology and Forensic Medicine 67
Replace Yi Fritz with:
Yi Fritz United States
Iwao Isomura Japan
Yuki Ichimura Japan
Greggory S. LaBerge United States
Brandon G. Howell United States
Hideaki Sugiyama Japan
Xiulan Qi United States
Zsofia Bittner Germany
Daniel Schmitt France
Akiko Nishibu Japan
Mark Mellett relative to Yi Fritz United States Yi Fritz's profile →
Citations per field
00.5×1.7×
Yi Fritz · 1×
Citations per year

Countries citing papers authored by Mark Mellett

Since Specialization
Citations

This map shows the geographic impact of Mark Mellett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mellett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mellett more than expected).

Fields of papers citing papers by Mark Mellett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mellett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mellett. The network helps show where Mark Mellett may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Mellett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Mellett Line = papers co-authored together Mark Mellett links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20246
3 202412
4 20243
5 20241
6 202323
7 20224
8 20229
9 202110
10 202164
11 20212
12 20215
13 202124
14 202015
15 201938
16 201869
17 201853
18 20180
19 201855
20 201260

About Mark Mellett

Mark Mellett is a scholar working on Immunology, Dermatology, Cancer Research, Rheumatology and Molecular Biology, having authored 30 papers that have together received 674 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (8 papers), Psoriasis: Treatment and Pathogenesis (8 papers), Immune Response and Inflammation (7 papers), Dermatology and Skin Diseases (6 papers), RNA Interference and Gene Delivery (5 papers), Urticaria and Related Conditions (4 papers), NF-κB Signaling Pathways (4 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Dermatology (167 citations), Immunology (360 citations), Cancer Research (80 citations), Rheumatology (60 citations) and Pathology and Forensic Medicine (67 citations). Mark Mellett has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Lars E. French, Paul N. Moynagh, Takashi Satoh, Laura Israël, Emmanuel Contassot, Paola Atzei, Ruaidhrí Jackson, Thomas M. Kündig, Steve Pascolo and Barbara Meier. Their work appears in journals such as Nature Communications, Journal of Investigative Dermatology, Cell Death and Disease, Frontiers in Immunology and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026